KevinBradleyKaisermanMD
Pediatric Endocrinology • West Covina, CAAssistant Professor, Pediatrics, UCLA School of Medicine
Dr. Kaiserman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1401 W Merced Ave
Ste 101
West Covina, CA 91790Phone+1 626-813-9988Fax+1 626-813-0075
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Endocrinology, 1995 - 1998- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1992 - 1995
Eastern Virginia Medical SchoolClass of 1992
Certifications & Licensure
CA State Medical License 1994 - 2026- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
- Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes Start of enrollment: 2016 Apr 18
- Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System Start of enrollment: 2019 Jul 24
Publications & Presentations
PubMed
- 6 citationsSafety and Glycemic Outcomes During the MiniMedAdvanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes.Catherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, Kevin B Kaiserman, Jennifer L Sherr
Diabetes Technology & Therapeutics. 2023-11-01 - 12 citationsGlycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor.Toni L Cordero, Zheng Dai, Arcelia Arrieta, Fang Niu, Melissa Vella
Diabetes Technology & Therapeutics. 2023-09-01 - 20 citationsImproved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.Satish K Garg, George Grunberger, Ruth Weinstock, Margaret L Lawson, Irl B Hirsch
Diabetes Technology & Therapeutics. 2023-01-01
Press Mentions
- MannKind Presents Data at 21st Annual Diabetes Technology MeetingNovember 5th, 2021
- MannKind Announces Data Presentation at 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2021) to Be Held Virtually June 2-5June 3rd, 2021
Medtronic Wins FDA’s Breakthrough Status for Closed-Loop Insulin SystemFebruary 19th, 2019- Join now to see all
Grant Support
- DAX1 Function In Adrenocortical DevelopmentNational Institute Of Diabetes And Digestive And Kidney Diseases1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
